EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort

Jennifer Hendrick iD, Jennie Z Ma iD, Vu Huynh, Jozelyn V Pablo iD, Andy A Teng, Amit Oberai iD, Joseph J Campo iD, David Camerini iD, William A Petri

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiaf558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Jennifer Hendrick und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Adenovirus Infections, Human, Adenoviruses, Human, Gastroenteritis. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adenovirus (AdV) 40/41 is a major cause of pediatric acute gastroenteritis (AGE), leading to significant morbidity and mortality worldwide. As little is known about clinical correlates of protection, we analyzed AdV-specific antibody reactivities using a multi-AdV protein microarray and serum from a Bangladeshi birth cohort surveilled for diarrhea during the first 2 years of life.

Methods

Arrays contained a comprehensive set of proteins from AdV 40 and 41, in addition to respiratory AdVs 4, 5, and 26. Children were split into four groups according to AdV 40/41 infection occurrence during year 1 (Y1) and year 2 (Y2) of life. One-year array antibody reactivity levels were analyzed from 119 children using principal component analysis (PCA). Top antibody reactivities were evaluated for associations with AdV 40/41 disease severity and protection in Year 2 using logistic regression.

Results

Eight principal components (PCs) were identified from PCA. Top targets contributing to the leading PCs included external AdV 40/41 antigens that function in host cell entry, particularly penton base (PB) proteins. AdV 41 PB antibody reactivity at Year 1 is significantly associated with reduced risk of AdV 40/41 infection in Year 2 (OR = 0.36, 95% CI: 0.16–0.80, P = .013, adjusted P = .003). Additionally, those with mild to moderate infections in Year 2 had higher reactivities to AdV 40 and 41 PB compared to severe infections (P = .008 and .032, respectively).

Conclusions

Higher antibody reactivity to AdV PB was associated with improved Year 2 AdV 40/41 outcomes, elevating it as a promising vaccine or monoclonal antibody target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralAdenovirus Infections, HumanAdenoviruses, HumanGastroenteritisAdenoviridae InfectionsHumansBangladeshInfantFemaleMaleBirth CohortChild, PreschoolCohort StudiesProtein Array AnalysisDiarrheaPrincipal Component Analysis

Stichwörter der Autor:innen

adenovirus 40/41antibody responsepediatric gastroenteritis

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
  • Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Antigen Discovery Incorporated (ADI), Irvine California, USA.
  • Center for Virus Research, University of California, Irvine, California, USA.
  • Department of Developmental and Cell Biology, University of California, Irvine, California, USA.
  • Department of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, Virginia, USA.

ORCID-Profile: Jennifer Hendrick, Jennie Z Ma, Jozelyn V Pablo, Amit Oberai, Joseph J Campo, David Camerini

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Allergy and Infectious Diseases
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Hendrick, J., Ma, J. Z., Huynh, V., Pablo, J. V., Teng, A. A., Oberai, A., Campo, J. J., Camerini, D., & Petri, W. A. (2026). Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf558

Vancouver

Hendrick J, Ma JZ, Huynh V, Pablo JV, Teng AA, Oberai A, et al. Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf558

BibTeX
@article{Hendrick2026,
  author = {Hendrick, Jennifer and Ma, Jennie Z and Huynh, Vu and Pablo, Jozelyn V and Teng, Andy A and Oberai, Amit and Campo, Joseph J and Camerini, David and Petri, William A},
  title = {Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiaf558}
}
Kostenlos starten →